DOJ's FCPA Unit Probing Pfizer
DOJ’s Foreign Corrupt Practices Act Unit is investigating U.S. pharmaceutical company Pfizer for its activities in Mexico, the company disclosed in an SEC filing this month. Pfizer said the agency’s FCPA Unit sent an “informal request” in March “seeking documents…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
relating to our operations in Mexico.” The company is “producing records pursuant to this request.” The probe comes after Pfizer in 2012 reached an agreement with DOJ to resolve FCPA violation charges and as the company handles requests from the FPCA unit for activities in China and Russia, according to its SEC filing.